Literature DB >> 23547679

Clinical and diagnostic features of inflammatory airway disease subtypes in horses examined because of poor performance: 98 cases (2004-2010).

Rose D Nolen-Walston1, Michelle Harris, Morgan E Agnew, Benson B Martin, Virginia B Reef, Raymond C Boston, Elizabeth J Davidson.   

Abstract

OBJECTIVE: To determine whether there are important differences relating to seasonality of signs or clinical features between subtypes of inflammatory airway disease (IAD) in horses caused by neutrophilic and eosinophilic-mastocytic inflammation having dissimilar etiopathologic pathways.
DESIGN: Retrospective case series. ANIMALS: 98 horses. PROCEDURES: Data were compiled from medical records of horses examined because of poor performance from 2004 through 2010. Horses underwent a standardized high-speed treadmill test, lameness evaluation, cardiac evaluation, and postexercise bronchoalveolar lavage (BAL). By means of standard BAL cytologic criteria, horses were divided into 4 groups: eosinophilic-mastocytic inflammation, neutrophilia only, mixed inflammation, or no inflammation (control). Associations between IAD subtype and clinical parameters were investigated.
RESULTS: Data for 98 horses were obtained, including age, career, season of admission, and results of hematologic evaluation, high-speed treadmill arterial blood gas analysis, upper airway endoscopy, cardiologic evaluation, and BAL. Cytologic evidence of IAD was found in 81% (79/98) of the horses, and 30% (30/98) had erythrocytes present in the BAL fluid after exercise. Horses in the eosinophilic-mastocytic inflammation and mixed-inflammation groups were significantly more likely to be Thoroughbred than Standardbred and have larger amounts of mucus in their BAL fluid. No significant differences were found in season of evaluation, results of exercising blood gas analyses, or comorbidities. CONCLUSIONS AND CLINICAL RELEVANCE: No association between season and cytologic profile of BAL fluid and no major effects of IAD subtype on pulmonary gas exchange during exercise were seen in this population of horses.

Entities:  

Mesh:

Year:  2013        PMID: 23547679     DOI: 10.2460/javma.242.8.1138

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  6 in total

1.  Inflammatory Airway Disease of Horses--Revised Consensus Statement.

Authors:  L L Couëtil; J M Cardwell; V Gerber; J-P Lavoie; R Léguillette; E A Richard
Journal:  J Vet Intern Med       Date:  2016-01-24       Impact factor: 3.333

2.  Increased Weekly Mean PM2.5, and NO2 Are Associated With Increased Proportions of Lower Airway Granulocytes in Ontario Horses.

Authors:  Gabrielle Brankston; Amy L Greer; Quinn Marshall; Brittany Lang; Kai Moore; Douglas Hodgins; John T G Hennessey; Janet Beeler-Marfisi
Journal:  Front Vet Sci       Date:  2020-05-05

3.  The Relationship between Lung Inflammation and Aerobic Threshold in Standardbred Racehorses with Mild-Moderate Equine Asthma.

Authors:  Luca Stucchi; Elena Alberti; Giovanni Stancari; Bianca Conturba; Enrica Zucca; Francesco Ferrucci
Journal:  Animals (Basel)       Date:  2020-07-27       Impact factor: 2.752

4.  Associations between Exercise-Induced Pulmonary Hemorrhage (EIPH) and Fitness Parameters Measured by Incremental Treadmill Test in Standardbred Racehorses.

Authors:  Chiara Maria Lo Feudo; Luca Stucchi; Giovanni Stancari; Elena Alberti; Bianca Conturba; Enrica Zucca; Francesco Ferrucci
Journal:  Animals (Basel)       Date:  2022-02-12       Impact factor: 2.752

5.  Environmental exposures and airway inflammation in young thoroughbred horses.

Authors:  K M Ivester; L L Couëtil; G E Moore; N J Zimmerman; R E Raskin
Journal:  J Vet Intern Med       Date:  2014-03-12       Impact factor: 3.333

6.  An observational study of environmental exposures, airway cytology, and performance in racing thoroughbreds.

Authors:  Kathleen M Ivester; Laurent L Couëtil; George E Moore
Journal:  J Vet Intern Med       Date:  2018-09-17       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.